Manufacturers of pharmaceuticals, dietary supplements and ingredients will soon face profound changes to requirements for measuring trace elements in their products. Stringent rules for monitoring lists of target elements will replace 100-year-old, imprecise, wet chemistry procedures applied to a wide range of products that are ingested, inhaled, absorbed through the skin or injected.
To help organizations throughout pharmaceutical/nutraceutical value chains cope with these new guidelines, Thermo Fisher Scientific has assembled an online site containing many resources to help visitors understand the pending revisions to the US Pharmacopeia’s National Formulary chapters <232>, <233> and <2232> describing the new permissible levels and monitoring procedures respectively. The site is designed to provide clear insight into options for accommodating these new requirements.
The resource can be accessed at http://www.thermoscientific.com/usp232-233.
The site contains a talk by industry expert Rob Thomas explaining the impact of the pending USP chapter revisions and resources by Thermo Fisher experts in applying technology to elemental analysis. It also contains on-demand webinars about nuances of accommodating the new guidelines. There are also application notes and technical notes along with links to related instrumentation.